These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30641417)

  • 41. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
    Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
    Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comparative Analysis of Early T-Cell Precursor Lymphoblastic Leukemia/Lymphoma (ETP-ALL/LBL) and Non-ETP-ALL/LBL in a Tertiary Cancer Care Center Based in Western India.
    Saha A; Brahmbhatt B; Rai V; Kakoty S; Sawhney J
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):699-704. PubMed ID: 37786816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed.
    Suo S; Sun S; Nguyen LXT; Qian J; Li F; Zhao D; Yu W; Lou Y; Zhu H; Tong H; Yang M; Huang X; Zhao S; Qiao J; Liang C; Wang H; Zhang Y; Zhang X; Hoang DH; Chen F; Kang H; Valerio M; Sun J; Ghoda L; Li L; Marcucci G; Zhang B; Jin J
    Med; 2024 Dec; 5(12):1510-1524.e4. PubMed ID: 39151422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL.
    Tavakoli Shirazi P; Eadie LN; Heatley SL; Hughes TP; Yeung DT; White DL
    Br J Cancer; 2020 Feb; 122(4):455-464. PubMed ID: 31792348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in children.
    Summers RJ; Teachey DT; Hunger SP
    Blood; 2024 Feb; ():. PubMed ID: 38364183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient.
    Kawashima-Goto S; Imamura T; Seki M; Kato M; Yoshida K; Sugimoto A; Kaneda D; Fujiki A; Miyachi M; Nakatani T; Osone S; Ishida H; Taki T; Takita J; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Hosoi H
    Int J Hematol; 2015 Apr; 101(4):411-6. PubMed ID: 25430085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimal drug prediction from personal genomics profiles.
    Sheng J; Li F; Wong ST
    IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report.
    Iqbal N; Sharma A; Raina V; Kumar L; Bakhshi S; Kumar R; Gajendra S
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):215-8. PubMed ID: 25435716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-associated immune parameters for personalized patient care.
    Pagès F
    Sci Transl Med; 2013 Dec; 5(214):214fs42. PubMed ID: 24307691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
    Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
    Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.
    Fransecky L; Neumann M; Heesch S; Schlee C; Ortiz-Tanchez J; Heller S; Mossner M; Schwartz S; Mochmann LH; Isaakidis K; Bastian L; Kees UR; Herold T; Spiekermann K; Gökbuget N; Baldus CD
    J Hematol Oncol; 2016 Sep; 9(1):95. PubMed ID: 27658391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.
    Summers RJ; Jain J; Vasileiadi E; Smith B; Chimenti ML; Yeung TY; Kelvin J; Wang X; Frye SV; Earp HS; Tyner JW; Dreaden EC; DeRyckere D; Graham DK
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early T-cell precursor leukemia/lymphoma in adults and children.
    Allen A; Sireci A; Colovai A; Pinkney K; Sulis M; Bhagat G; Alobeid B
    Leuk Res; 2013 Sep; 37(9):1027-34. PubMed ID: 23827350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
    Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
    Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
    Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
    Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.
    Tasian SK; Hunger SP
    Br J Haematol; 2017 Mar; 176(6):867-882. PubMed ID: 27984637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.